Health centers have been integral to our country’s efforts in managing the pandemic. Since April of 2020, health centers have tested 17 million patients* using – in many cases – available rapid tests.
Sofia is a rapid point-of-care test using nasal specimens from patients suspected of COVID-19 infection. Using fluorescent chemistry design, Sophia provides an accurate, objective, and automated result in 15 minutes. Testing is authorized to be performed at moderate complexity/high complexity laboratories, or at the Point of Care (POC) inpatient care settings operating under a CLIA Certificate of Waiver. Sofia rapid test kits are also easy to use and adaptable to any healthcare setting.